Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by NBT Bank N A NY

NBT Bank N A NY lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 28.0% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 2,489 shares of the medical equipment provider’s stock after purchasing an additional 544 shares during the quarter. NBT Bank N A NY’s holdings in Intuitive Surgical were worth $1,299,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. M.E. Allison & CO. Inc. acquired a new position in shares of Intuitive Surgical during the 4th quarter worth $449,000. Seilern Investment Management Ltd acquired a new position in shares of Intuitive Surgical during the 4th quarter worth $82,517,000. Sycomore Asset Management grew its stake in shares of Intuitive Surgical by 27.4% during the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock worth $9,214,000 after purchasing an additional 4,079 shares during the period. Exome Asset Management LLC grew its stake in shares of Intuitive Surgical by 16.8% during the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after purchasing an additional 1,069 shares during the period. Finally, China Universal Asset Management Co. Ltd. grew its stake in shares of Intuitive Surgical by 5.6% during the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock worth $5,138,000 after purchasing an additional 525 shares during the period. 83.64% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on ISRG shares. Truist Financial upped their price target on shares of Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a research note on Friday, January 24th. Leerink Partners boosted their price objective on shares of Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Raymond James boosted their price objective on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. Piper Sandler reiterated an “overweight” rating and issued a $670.00 price objective (up from $538.00) on shares of Intuitive Surgical in a research report on Friday, January 24th. Finally, Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and boosted their price objective for the stock from $522.00 to $650.00 in a research report on Monday, December 2nd. One analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have assigned a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $613.10.

Insider Activity

In other news, SVP Mark Brosius sold 489 shares of the company’s stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $533.18, for a total transaction of $260,725.02. Following the completion of the transaction, the senior vice president now owns 2,091 shares of the company’s stock, valued at $1,114,879.38. This represents a 18.95 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, VP Fredrik Widman sold 810 shares of the stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $573.78, for a total transaction of $464,761.80. Following the sale, the vice president now directly owns 473 shares of the company’s stock, valued at approximately $271,397.94. This trade represents a 63.13 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 13,309 shares of company stock valued at $7,611,004 in the last 90 days. 0.90% of the stock is currently owned by insiders.

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $482.61 on Tuesday. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The company has a 50-day moving average of $570.48 and a 200-day moving average of $531.79. The company has a market cap of $171.90 billion, a P/E ratio of 75.29, a P/E/G ratio of 5.85 and a beta of 1.43.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.